(Q34040596)

30 July 2017

1 reference

title

Breakthrough pain in cancer patients: new therapeutic approaches to an old challenge (English)

1 reference

30 July 2017

Reddy SK

1

1 reference

30 July 2017

Nguyen P

series ordinal

2

1 reference

30 July 2017

publication date

1 January 2000

1 reference

30 July 2017

published in

Current review of pain

1 reference

30 July 2017

volume

4

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

242-247

1 reference

Breakthrough pain: definition, prevalence and characteristics

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11916-000-0086-3

The Edmonton staging system for cancer pain: preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-000-0086-3

Predictive factors in advanced cancer pain treated only by analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-000-0086-3

Pain characteristics of advanced lung cancer patients referred to a palliative care service

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-000-0086-3

Breakthrough pain: characteristics and impact in patients with cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-000-0086-3

Psoas sheath chemical neurolysis for management of intractable leg pain from metastatic liposarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-000-0086-3

The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-000-0086-3

The use of corticosteroids in the treatment of symptoms associated with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-000-0086-3

Role of rectal route in treating cancer pain: a randomized crossover clinical trial of oral versus rectal morphine administration in opioid-naive cancer patients with pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-000-0086-3

Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-000-0086-3

Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-000-0086-3

Breakthrough pain in cancer patients: characteristics, prevalence, and treatment.

21 January 2018

1 reference

12 December 2020

Percutaneous Radiofrequency Cervical Cordotomy: Technique

1 reference

12 December 2020

Management of breakthrough pain due to cancer.

1 reference

12 December 2020

Absorption and Bioavailability of Oral Transmucosal Fentanyl Citrate

1 reference

12 December 2020

The role of bisphosphonates in malignant bone pain: a review

1 reference

12 December 2020

Epidural clonidine analgesia for intractable cancer pain: phase I.

1 reference

12 December 2020

Subarachnoid neurolytic block under general anesthesia in a 3-year-old with neuroblastoma.

1 reference

12 December 2020

A prospective multicenter assessment of the Edmonton staging system for cancer pain

1 reference

12 December 2020

Continuous narcotic infusion with patient-controlled analgesia for chronic cancer pain in outpatients

1 reference

12 December 2020

The use of methylphenidate in patients with incident cancer pain receiving regular opiates. A preliminary report

1 reference

12 December 2020

10.1007/S11916-000-0086-3

Identifiers

DOI

1 reference

30 July 2017

1 reference